InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Zachary Jennifer, Directeur Juridique. Officer active across 2 companies, notably Merck & Co., Inc.. In total, 20 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €11.3m. Activity tracked since 4 May 2021. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Zachary Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
41,494 股@ US$117.89Common StockSEC:0000310158-26-000221:0
13,433 股@ US$84.71Common StockSEC:0000310158-26-000221:1
80,315 股@ US$133.4557Common StockSEC:0000310158-26-000221:2
2,951 股@ US$110.030.0001% mcap1.7% 占其流量Common StockSEC:0000310158-26-000086:0
1,454 股@ US$110.030.0001% mcap0.9% 占其流量Common StockSEC:0000310158-26-000086:1
25,946 股@ US$119.152213.3% 占其流量Common StockSEC:0000310158-26-000046:0
11,583 股@ US$107.405.3% 占其流量Common StockSEC:0000310158-26-000028:0
7,768 股0Common StockSEC:0001562180-25-004354:0
25,423 股@ US$97.9415.3% 占其流量Common StockSEC:0001127602-25-002357:0
4,790 股0Common StockSEC:0001562180-24-004656:0
19,417 股@ US$87.1010.0% 占其流量Common StockSEC:0001127602-24-003093:0
23,298 股@ US$119.4316.4% 占其流量Common StockSEC:0001127602-24-002026:0
3,486 股0Common StockSEC:0001562180-23-004888:0
19,141 股@ US$117.592313.1% 占其流量Common StockSEC:0001127602-23-014759:0
75,436 股@ US$56.0424.9% 占其流量Common StockSEC:0001127602-23-003562:0
15,631 股@ US$109.8810.2% 占其流量Common StockSEC:0001127602-23-002228:0
68,367 股0Common StockSEC:0001127602-22-024595:0
6,020 股0Common StockSEC:0001562180-22-004883:0
18,420 股@ US$73.516.1% 占其流量Common StockSEC:0001127602-22-007033:0
5,772 股@ US$75.981.9% 占其流量Common StockSEC:0001127602-21-015758:0
20 条申报中的 20 条
About Zachary Jennifer
Zachary Jennifer is Director Juridique. He is associated with Merck & Co., Inc. as EVP, General Counsel, and with REGENXBIO Inc. as Director. He has 17 filings in total, and across the sampled recent filings the period runs from 2021-05-06 to 2026-05-01, with EUR 0 of buys and EUR 2,041,957 of sells.
